Antios Therapeutics is Drug Discovery in United States that focus on Inhibitor Nucleotide business. Founded in 2018. They cover business area such as clevudine, unique antiviral property, HBV polymerase, potent HBV antiviral activity, off-treatment suppression, HBV DNA, healthcare professional, chronic hepatitis B infect patient, high level, systemic exposure.
2018
( 6 years old in 2024 )
Inhibitor Nucleotide
-
575 Pharr Road North East
Suite 12260
Atlanta, GA 30355
United States
Private
clevudineunique antiviral propertyHBV polymerasepotent HBV antiviral activityoff-treatment suppressionHBV DNAhealthcare professionalchronic hepatitis B infect patienthigh levelsystemic exposure
* We use standard office opening hours in near Antios Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Antios Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Antios Therapeutics business is focusing on Inhibitor Nucleotide.
Antios Therapeutics headquarter office and corporate office address is located in 575 Pharr Road North East Suite 12260 Atlanta, GA 30355 United States.
Antios Therapeutics was founded in United States.
In 2024, Antios Therapeutics is currently focus on Inhibitor Nucleotide sector.
Above is snippet of Google Trends for "Inhibitor Nucleotide" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Antios Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
